Inventor · disambiguated record
Stefan Radtke
Also filed as: RADTKE STEFAN
2 granted patents·5 pending applications·0 citations·filing 2017–2023
28Inventor score
Files withFRED HUTCHINSON CANCER CENTER4Fred Hutchison Cancer Center1HUTCHINSON FRED CANCER RES1UNIV PENNSYLVANIA1
Top patents by PatentIndex Score
7 records- 0173US12295973B2Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cellsFRED HUTCHINSON CANCER CENTER·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 0258US11786557B2Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cellsFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Oct 17, 2023·0 cites·19 claims
- 0358US2024238438A1CD-90 Targeted Lipid NanoparticlesUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 0458US2025249125A1Anti-cd90 antibodies, binding fragments, and uses thereofFred Hutchison Cancer Center·Filed 2023·Application pending·0 cites
- 0555US2023159895A1Strategies to assess and/or produce cell populations with predictive engraftment potentialFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 0652US2025049887A1Methods and compositions for modulating the myeloid arm of the immune systemFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 0733US2019345450A1Strategies to assess and/or produce cell populations with predictive engraftment potentialHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Radtke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →